A small protein molecule, engineered through computer design, protects against diverse strains of influenza in mice. Its preventive and therapeutic power does not depend on the animals’ own immune response to viral infection.
The potential of modular design for brand new proteins that do not yet exist in the natural world is explored Dec. 16 in the journal Nature.
A team at the University of Washington is developing an enzyme aimed at enabling people with Celiac disease to safely eat foods with gluten.
A route for constructing protein nanomachines engineered for specific applications may be closer to reality.
